These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16126281)

  • 41. [Activation of psoriasis in patients undergoing treatment with interferon-beta].
    Navne JE; Hedegaard U; Bygum A
    Ugeskr Laeger; 2005 Aug; 167(32):2903-4. PubMed ID: 16109199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apoptosis-related molecules in blood in multiple sclerosis.
    Rinta S; Kuusisto H; Raunio M; Paalavuo R; Levula M; Lehtimäki T; Elovaara I
    J Neuroimmunol; 2008 Dec; 205(1-2):135-41. PubMed ID: 18963025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity.
    Hesse D; Sellebjerg F; Sorensen PS
    Neurology; 2009 Aug; 73(5):372-7. PubMed ID: 19652141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
    Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F
    J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of gene expression in RAW 264.7 macrophage cell line by interferon-gamma.
    Kota RS; Rutledge JC; Gohil K; Kumar A; Enelow RI; Ramana CV
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1137-46. PubMed ID: 16516165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene expression analysis of interferon-beta treatment in multiple sclerosis.
    Sellebjerg F; Datta P; Larsen J; Rieneck K; Alsing I; Oturai A; Svejgaard A; Soelberg Sørensen P; Ryder LP
    Mult Scler; 2008 Jun; 14(5):615-21. PubMed ID: 18408020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment?
    Drulovic J; Savic E; Pekmezovic T; Mesaros S; Stojsavljevic N; Dujmovic-Basuroski I; Kostic J; Vasic V; Mostarica Stojkovic M; Popadic D
    J Neuroimmunol; 2009 Oct; 215(1-2):90-5. PubMed ID: 19695714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays.
    Jaber A; Baker M
    J Pharm Biomed Anal; 2007 Mar; 43(4):1256-61. PubMed ID: 17118612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ; Krakauer M; Bendtzen K; Sørensen PS; Sellebjerg F; Nielsen CH
    Clin Immunol; 2008 Oct; 129(1):80-9. PubMed ID: 18653385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patients.
    Castelli-Haley J; Oleen-Burkey M; Lage MJ; Johnson KP
    Adv Ther; 2008 Jul; 25(7):658-73. PubMed ID: 18641926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis.
    Wenzel J; Schmidt R; Proelss J; Zahn S; Bieber T; Tüting T
    Clin Exp Dermatol; 2006 Jul; 31(4):576-82. PubMed ID: 16716166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets.
    Wenzel J; Zahn S; Mikus S; Wiechert A; Bieber T; Tüting T
    Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
    Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
    Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon-beta1b in multiple sclerosis.
    Buttmann M; Rieckmann P
    Expert Rev Neurother; 2007 Mar; 7(3):227-39. PubMed ID: 17341170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-β but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: a clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs.
    Rotondi M; Stufano F; Lagonigro MS; La Manna L; Zerbini F; Ghilotti S; Pagliari MT; Coperchini F; Magri F; Bergamaschi R; Oliviero A; Chiovato L
    J Neuroimmunol; 2011 May; 234(1-2):161-4. PubMed ID: 21371758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
    Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
    Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lupus erythematosus profundus (lupus panniculitis) induced by interferon-beta in a multiple sclerosis patient.
    Gono T; Matsuda M; Shimojima Y; Kaneko K; Murata H; Ikeda S
    J Clin Neurosci; 2007 Oct; 14(10):997-1000. PubMed ID: 17669654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon beta-1a overdose in a multiple sclerosis patient.
    Falcone NP; Nappo A; Neuteboom B
    Ann Pharmacother; 2005 Nov; 39(11):1950-2. PubMed ID: 16204396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CXC and CC chemokines induced in human renal epithelial cells by inflammatory cytokines.
    Thorburn E; Kolesar L; Brabcova E; Petrickova K; Petricek M; Jaresova M; Slavcev A; Striz I
    APMIS; 2009 Jul; 117(7):477-87. PubMed ID: 19594487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.